What were once hot health care commodities during the pandemic are now laggards as both Remdesivir (Gilead) and Tocilizumab (Roche) barely see shelf movement despite…
In the Philippines, the national Food and Drug Administration (FDA) has followed the World Health Organization (WHO) edict that the current ivermectin research targeting COVID-19…
Recent disclosure of Pfizer executives telling investors about the profit potential of its vaccine raises the issue of money in the drug industry. On the…
Recently, a committed non-profit organization known as Doctors Without Borders/Médecins Sans Frontières (MSF) issued a call for more transparency in clinical research. In a bold statement, the…
The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription drugs in the United States.…
Not widely known outside of drug pricing policy and business experts, the Boston-based nonprofit organization known as the Institute for Clinical and Economic Review (ICER)…
Danish drug maker Novo Nordisk, a leading producer of diabetes drugs, recently announced it extended its COVID-19 Patient Assistance Program until June 30, 2021 for…
On Oct. 9, TrialSite reported Eli Lilly could be on the verge of securing an emergency use authorization (EUA) from the U.S. Food and Drug Administration…
Sao Paulo state government in Brazil has requested from Brazil’s national health regulator, Anvisa, to register CoronaVac, the vaccine candidate developed by China’s Sinovac Biotech Ltd,…
Congress’ Committee on Oversight and Reform recently detailed a sweeping investigation into “skyrocketing prices of prescription drugs.” The Congressional Committee zeroed in on Celgene and Bristol…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
